Fei Xue

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Abdominal Aortic

Vascular Smooth Muscle Cells

Lipopolysaccharide Induced

Top Venues

Science advances

Cell death and differentiation

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Linlin Meng, Yue Lu, Xinlu Wang, Cheng Cheng, Fei Xue, Lin Xie, Yaoyuan Zhang, Wenhai Sui, Meng Zhang, Yun Zhang, Cheng Zhang
NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways. Science advances 9 (31) (2023)
Jie Zhang, Lei Cao, Xiaohong Wang, Qian Li, Meng Zhang, Cheng Cheng, Liwen Yu, Fei Xue, Wenhai Sui, Shangwen Sun, Na Li, Peili Bu, Bingyu Liu, Fei Gao, Junhui Zhen, Guohai Su, Cheng Zhang, Chengjiang Gao, Meng Zhang, Yun Zhang
The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-β1 signaling pathway. Cell death and differentiation (2021)
Fei Xue, Jianmin Yang, Jing Cheng, Wenhai Sui, Cheng Cheng, Hongxuan Li, Meng Zhang, Jie Zhang, Xing Li Xu, Jing Ma, Lin Lu, Jinfeng Xu, Meng Zhang, Yun Zhang, Cheng Zhang
Angiotensin-(1-7) mitigated angiotensin II-induced abdominal aortic aneurysms in apolipoprotein E-knockout mice. British journal of pharmacology 177 (8) (2020)